Chugai and GSK sign collaboration agreement for anti-dengue virus antibody AID351

Japan's Chugai Pharmaceutical Co. has signed a collaboration agreement with GSK's Global Health Unit (GSK GH) for&n...

January 31, 2025 | Friday | News
“There remains a high unmet need for new & alternative treatment options for prurigo nodularis & atopic dermatitis”

What major plans are in store for the company (Asia Pacific region & global) in 2025? We’re going to keep del...

February 1, 2025 | Saturday | Opinion
APAC takes centre-stage in AI-driven drug discovery

Drug discovery is a lengthy and costly process, typically requiring billions of dollars and nearly a decade to bring a d...

February 1, 2025 | Saturday | Analysis
GHIT announces $12.7 M worth investment for developing diagnostics and drugs for malaria, NTDs

The Global Health Innovative Technology (GHIT) Fund, headquartered in Japan, has announced a total investment of approxi...

January 31, 2025 | Friday | News
Japan's ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research

Japan-based startup ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis...

January 29, 2025 | Wednesday | News
Australia's Inventia announces groundbreaking advancement in 3D cell culture technology

Inventia Life Science, an innovator in 3D cell culture technologies, has announced the launch of RASTRUM Allegro, a...

January 28, 2025 | Tuesday | News
AB2 Bio signs licensing agreement worth $500 M with Nippon Shinyaku for ultra-rare autoimmune disease treatment

AB2 Bio, a biotechnology company developing innovative therapies for the treatment of severe systemic hyperinflammatory ...

January 28, 2025 | Tuesday | News
Japan's Daiichi Sankyo establishes Smart research lab in US to expedite drug discovery

Japanese pharmaceutical firm Daiichi Sankyo has established a state-of-the-art research laboratory in San Diego, Ca...

January 23, 2025 | Thursday | News
Takeda, Tohoku University form alliance to strengthen drug discovery capabilities in Japan

Takeda Pharmaceutical Company and the Tohoku University Drug Discovery Strategy Promotion Organization have entered into...

December 18, 2024 | Wednesday | News
Eisai and Biogen Japan collaborate to lead dementia genomics R&D with NCNP in Japan

Eisai Co., Ltd. and Biogen Japan Ltd. have announced that Eisai has entered into a research collaboration agreement with...

November 26, 2024 | Tuesday | News
Hong Kong-based Insilico Medicine enters into revolving loan facility of up to $100 M with HSBC

Hong Kong-based Insilico Medicine, a global leading generative artificial intelligence (AI)-driven biotechnology company...

November 5, 2024 | Tuesday | News
Biomedical engineers in Australia design high-speed 3D bioprinter as gamechanger for drug discovery

Biomedical engineers from the University of Melbourne, Australia have invented a 3D printing system, or bioprinter, capa...

November 4, 2024 | Monday | News
Hong Kong Innovation Center opens to provide one-stop support for early-stage drug discovery

ATLATL Hong Kong Innovation Center, a new state-of-the-art research facility designed to provide immediate, move-in-read...

October 30, 2024 | Wednesday | News
Japan's Ono Pharma inks $700 M ADC deal with Korean firm LigaChem Biosciences

Japan-based Ono Pharmaceutical Co. has entered into a license agreement with LigaChem Biosciences, Inc., in South Korea,...

October 14, 2024 | Monday | News
Japanese startup Alpha Fusion accelerates astatine-based drug discovery with Series B funding

Alpha Fusion, Inc., working on research outcomes from Osaka University and the Japan Science and Technolo...

October 13, 2024 | Sunday | News
World Companion Diagnostics and Liquid Biopsy Summit APAC to Unite 100+ Precision Medicine Experts

This exciting forum will gather the field to discuss the latest advancements in NGS, biomarker development, clinical tri...

October 10, 2024 | Thursday | News
Eli Lilly invests $4.5 B to create Lilly Medicine Foundry for drug development

American pharmaceutical firm Eli Lilly and Company has announced a $4.5 billion investment to create the Lilly...

October 4, 2024 | Friday | News
BIOCHINA 2025: China’s Largest Bio Convention to Host Over 3,000 Biotech Companies

Looking ahead, BIOCHINA 2025 has officially announced its next conference, set for March 13-15, 2025. The 10th edition o...

September 12, 2024 | Thursday | News